Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Yaron Ilan. (2019) Why targeting the microbiome is not so successful: can randomness overcome the adaptation that occurs following gut manipulation?. Clinical and Experimental Gastroenterology 12, pages 209-217.
Read now
Read now
Articles from other publishers (48)
Biplab Singha, Bhupendra Singh Rawat, Ramya Venkataraman, Tripti Nair, Eric H. Rosenn & Vijay Soni. (2023) Gut microbiome associated dysbiosis: Limited regimens and expanding horizons of phage therapy. Aspects of Molecular Medicine 2, pages 100029.
Crossref
Crossref
Chun Fu, Assar Ali Shah, Rifat Ullah Khan, Muhammad Shuaib Khan & Metha Wanapat. (2023) Emerging trends and applications in health-boosting microorganisms-specific strains for enhancing animal health. Microbial Pathogenesis 183, pages 106290.
Crossref
Crossref
Mengchen Liu, Jiaqiang Xu, Qianna Jin & Yunqiao Li. (2023) Interaction of Intestinal Microbiota with Medications. Current Drug Metabolism 24:8, pages 554-567.
Crossref
Crossref
Magdy El‐Salhy, Odd Helge Gilja & Jan Gunnar Hatlebakk. (2023) Factors affecting the outcome of fecal microbiota transplantation for patients with irritable bowel syndrome. Neurogastroenterology & Motility.
Crossref
Crossref
Elise Nordin, Per M. Hellström, Johan Dicksved, Erik Pelve, Rikard Landberg & Carl Brunius. (2023) Effects of FODMAPs and Gluten on Gut Microbiota and Their Association with the Metabolome in Irritable Bowel Syndrome: A Double-Blind, Randomized, Cross-Over Intervention Study. Nutrients 15:13, pages 3045.
Crossref
Crossref
Sofie Ingdam Halkjær, Bobby Lo, Frederik Cold, Alice Højer Christensen, Savanne Holster, Julia König, Robert Jan Brummer, Olga C Aroniadis, Perttu Lahtinen, Tom Holvoet, Lise Lotte Gluud & Andreas Munk Petersen. (2023) Fecal microbiota transplantation for the treatment of irritable bowel syndrome: A systematic review and meta-analysis. World Journal of Gastroenterology 29:20, pages 3185-3202.
Crossref
Crossref
Theodore Rokkas & Georgina L. Hold. (2023) A systematic review, pairwise meta-analysis and network meta-analysis of randomized controlled trials exploring the role of fecal microbiota transplantation in irritable bowel syndrome. European Journal of Gastroenterology & Hepatology 35:4, pages 471-479.
Crossref
Crossref
Wu Yanping, Xuefen Gao, Yizun Cheng, Mi Liu, Siyu Liao, Jing Zhou, Jiaming Hao, Gemeng Jiang, Yixuan Lu, Tianyao Qu, Bin Qin & Yan Cheng. (2022) The interaction between obesity and visceral hypersensitivity. Journal of Gastroenterology and Hepatology 38:3, pages 370-377.
Crossref
Crossref
Honghong Zhang, Lele Jing, Changlin Zhai, Qiannan Xiang, Hongen Tian & Huilin Hu. (2023) Intestinal Flora Metabolite Trimethylamine Oxide Is Inextricably Linked to Coronary Heart Disease. Journal of Cardiovascular Pharmacology 81:3, pages 175-182.
Crossref
Crossref
Motonobu Hamazaki, Tsunaki Sawada, Takeshi Yamamura, Keiko Maeda, Yasuyuki Mizutani, Eri Ishikawa, Satoshi Furune, Kenta Yamamoto, Takuya Ishikawa, Naomi Kakushima, Kazuhiro Furukawa, Eizaburo Ohno, Takashi Honda, Hiroki Kawashima, Masatoshi Ishigami, Masanao Nakamura & Mitsuhiro Fujishiro. (2022) Fecal microbiota transplantation in the treatment of irritable bowel syndrome: a single-center prospective study in Japan. BMC Gastroenterology 22:1.
Crossref
Crossref
Ya Feng, Lu Hang, Yan Zhou, Feng-Ru Jiang & Jian-Ye Yuan. (2022) Gut microbiota plays a role in irritable bowel syndrome by regulating 5-HT metabolism. World Chinese Journal of Digestology 30:21, pages 941-949.
Crossref
Crossref
Magdy El-Salhy, Renate Winkel, Christina Casen, Trygve Hausken, Odd Helge Gilja & Jan Gunnar Hatlebakk. (2022) Efficacy of Fecal Microbiota Transplantation for Patients With Irritable Bowel Syndrome at 3 Years After Transplantation. Gastroenterology 163:4, pages 982-994.e14.
Crossref
Crossref
Magdy El‐Salhy, Tarek Mazzawi, Trygve Hausken & Jan Gunnar Hatlebakk. (2022) Irritable bowel syndrome patients who are not likely to respond to fecal microbiota transplantation. Neurogastroenterology & Motility 34:9.
Crossref
Crossref
Yomna Ali Abdelghafar, Yossef Hassan AbdelQadir, Karam R. Motawea, Sara Amr Nasr, Hoda Aly Mohamed Omran, Mohamed Mohamed Belal, Mohamed Mahdy Elhashash, Ahmed Alaa AbdelAzim & Jaffer Shah. (2022) Efficacy and safety of fecal microbiota transplant in irritable bowel syndrome: An update based on meta‐analysis of randomized control trials. Health Science Reports 5:5.
Crossref
Crossref
Amir Minerbi & Shiqian Shen. (2022) Gut Microbiome in Anesthesiology and Pain Medicine. Anesthesiology 137:1, pages 93-108.
Crossref
Crossref
Magdy El‐Salhy, Anja Bråthen Kristoffersen, Jørgen Valeur, Christina Casen, Jan Gunnar Hatlebakk, Odd Helge Gilja & Trygve Hausken. (2021) Long‐term effects of fecal microbiota transplantation (FMT) in patients with irritable bowel syndrome. Neurogastroenterology & Motility 34:1.
Crossref
Crossref
Dariush Shahsavari & Henry P. Parkman. 2022. Nutrition, Weight, and Digestive Health. Nutrition, Weight, and Digestive Health
3
28
.
Fenghua Xu, Ning Li, Chun Wang, Hanyang Xing, Dongfeng Chen & Yanling Wei. (2021) Clinical efficacy of fecal microbiota transplantation for patients with small intestinal bacterial overgrowth: a randomized, placebo-controlled clinic study. BMC Gastroenterology 21:1.
Crossref
Crossref
Magdy El‐Salhy, Trygve Hausken & Jan Gunnar Hatlebakk. (2021) Current status of fecal microbiota transplantation for irritable bowel syndrome. Neurogastroenterology & Motility 33:11.
Crossref
Crossref
Jiaqu Cui, Zhiliang Lin, Hongliang Tian, Bo Yang, Di Zhao, Chen Ye, Ning Li, Huanlong Qin & Qiyi Chen. (2021) Long-Term Follow-Up Results of Fecal Microbiota Transplantation for Irritable Bowel Syndrome: A Single-Center, Retrospective Study. Frontiers in Medicine 8.
Crossref
Crossref
Gaia Anselmi, Lucilla Gagliardi, Gabriele Egidi, Sabrina Leone, Antonio Gasbarrini, Giacinto Abele Donato Miggiano & Leonarda Galiuto. (2020) Gut Microbiota and Cardiovascular Diseases. Cardiology in Review 29:4, pages 195-204.
Crossref
Crossref
Elemer Simon, Lavinia Florina Călinoiu, Laura Mitrea & Dan Cristian Vodnar. (2021) Probiotics, Prebiotics, and Synbiotics: Implications and Beneficial Effects against Irritable Bowel Syndrome. Nutrients 13:6, pages 2112.
Crossref
Crossref
Magdy El-Salhy, Tanisa Patcharatrakul & Sutep Gonlachanvit. (2021)
Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21
st
century
. World Journal of Gastroenterology 27:22, pages 2921-2943.
Crossref
Crossref
Jia-Yi Xu, Min-Ting Liu, Tao Tao, Xiao Zhu & Fang-Qin Fei. (2021) The role of gut microbiota in tumorigenesis and treatment. Biomedicine & Pharmacotherapy 138, pages 111444.
Crossref
Crossref
Tarek Mazzawi, Magdy El-Salhy, Gülen Arslan Lied & Trygve Hausken. (2021) The Effects of Fecal Microbiota Transplantation on the Symptoms and the Duodenal Neurogenin 3, Musashi 1, and Enteroendocrine Cells in Patients With Diarrhea-Predominant Irritable Bowel Syndrome. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Crossref
N. V. Sturov, S. V. Popov & V. A. Zhukov. (2021) Modern approaches to the correction of the gut microbiota. Meditsinskiy sovet = Medical Council:4, pages 136-143.
Crossref
Crossref
Valentin Mocanu, Sabitha Rajaruban, Jerry Dang, Janice Y. Kung, Edward C. Deehan & Karen L. Madsen. (2021) Repeated Fecal Microbial Transplantations and Antibiotic Pre-Treatment Are Linked to Improved Clinical Response and Remission in Inflammatory Bowel Disease: A Systematic Review and Pooled Proportion Meta-Analysis. Journal of Clinical Medicine 10:5, pages 959.
Crossref
Crossref
E Afecto, A Ponte, S Fernandes, J Silva, C Gomes, J Correia & J Carvalho. (2021) Fecal microbiota transplantation in hepatic encephalopathy : a review of the current evidence and future perspectives. Acta Gastro Enterologica Belgica 84:1, pages 87-90.
Crossref
Crossref
Magdy El‐Salhy, Jørgen Valeur, Trygve Hausken & Jan Gunnar Hatlebakk. (2020) Changes in fecal short‐chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome. Neurogastroenterology & Motility 33:2.
Crossref
Crossref
X. Meng, G. Zhang, H. Cao, D. Yu, X. Fang, W. M. Vos & H. Wu. (2020) Gut dysbacteriosis and intestinal disease: mechanism and treatment. Journal of Applied Microbiology 129:4, pages 787-805.
Crossref
Crossref
Magdy El-Salhy, Jan Gunnar Hatlebakk, Odd Helge Gilja, Anja Bråthen Kristoffersen & Trygve Hausken. (2020) Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study. Gut 69:5, pages 859-867.
Crossref
Crossref
Magdy El-Salhy. (2020) Possible role of intestinal stem cells in the pathophysiology of irritable bowel syndrome. World Journal of Gastroenterology 26:13, pages 1427-1438.
Crossref
Crossref
Lin Wang, Nuha Alammar, Rajdeep Singh, Julie Nanavati, Yiran Song, Rahul Chaudhary & Gerard E. Mullin. (2020) Gut Microbial Dysbiosis in the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies. Journal of the Academy of Nutrition and Dietetics 120:4, pages 565-586.
Crossref
Crossref
Amir Mari, Fadi Abu Baker, Mahmud Mahamid, Wisam Sbeit & Tawfik Khoury. (2020) The Evolving Role of Gut Microbiota in the Management of Irritable Bowel Syndrome: An Overview of the Current Knowledge. Journal of Clinical Medicine 9:3, pages 685.
Crossref
Crossref
Andrew Canakis, Mustafa Haroon & H. Christian Weber. (2020) Irritable bowel syndrome and gut microbiota. Current Opinion in Endocrinology, Diabetes & Obesity 27:1, pages 28-35.
Crossref
Crossref
Mahmoud A. ALI. (2020) The Relationship Between Affective Disorders and Pain: Focusing on the Functional Gastrointesinal Disorders such as Irritable Bowel Syndrome. Annals of the Academy of Romanian Scientists Series on Biological Sciences 9:2, pages 50-63.
Crossref
Crossref
Chuanxin Zhang, Junlin Huang, Yifan Ren, Shenghong Zhu, Fangxue Yin & Yixin Zhu. (2020) The Influence and Treatment of the Intestinal Microbiome on Child Respiratory Diseases. Infectious Microbes and Diseases 2:3, pages 107-114.
Crossref
Crossref
Magdy El-Salhy. (2019) Nutritional Management of Gastrointestinal Diseases and Disorders. Nutrients 11:12, pages 3013.
Crossref
Crossref
Thomas J Borody, Guy D Eslick & Robert L Clancy. (2019) Fecal microbiota transplantation as a new therapy: from Clostridioides difficile infection to inflammatory bowel disease, irritable bowel syndrome, and colon cancer. Current Opinion in Pharmacology 49, pages 43-51.
Crossref
Crossref
. (2019) UEG Week 2019 Oral Presentations. United European Gastroenterology Journal 7:S8, pages 10-188.
Crossref
Crossref
Jessica R. Allegretti, Zain Kassam, Monika Fischer, Colleen Kelly & Walter W. Chan. (2019) Risk Factors for Gastrointestinal Symptoms Following Successful Eradication of Clostridium difficile by Fecal Microbiota Transplantation (FMT). Journal of Clinical Gastroenterology 53:9, pages e405-e408.
Crossref
Crossref
Magdy El-Salhy, Jan Gunnar Hatlebakk & Trygve Hausken. (2019) Diet in Irritable Bowel Syndrome (IBS): Interaction with Gut Microbiota and Gut Hormones. Nutrients 11:8, pages 1824.
Crossref
Crossref
Magdy El-Salhy, Trygve Hausken & Jan Gunnar Hatlebakk. (2019) Increasing the Dose and/or Repeating Faecal Microbiota Transplantation (FMT) Increases the Response in Patients with Irritable Bowel Syndrome (IBS). Nutrients 11:6, pages 1415.
Crossref
Crossref
G. M. Sakhautdinova, R. R. Nagaeva & K. E. Asanbaeva. (2019) The modern ideas about the etiology of irritable bowel syndrome. Medical Council:3, pages 152-155.
Crossref
Crossref
Mengchao Jin, Zhiyuan Qian, Jiayu Yin, Weiting Xu & Xiang Zhou. (2019) The role of intestinal microbiota in cardiovascular disease. Journal of Cellular and Molecular Medicine 23:4, pages 2343-2350.
Crossref
Crossref
Julan Zhou, Zhongyin Zhou, Panpan Ji, Min Ma, Jinkun Guo & Shujuan Jiang. (2019) Effect of fecal microbiota transplantation on experimental colitis in mice. Experimental and Therapeutic Medicine.
Crossref
Crossref
Marines du Teil Espina, Giorgio Gabarrini, Hermie J M Harmsen, Johanna Westra, Arie Jan van Winkelhoff & Jan Maarten van Dijl. (2018) Talk to your gut: the oral-gut microbiome axis and its immunomodulatory role in the etiology of rheumatoid arthritis. FEMS Microbiology Reviews 43:1, pages 1-18.
Crossref
Crossref
Junchen Li, Huantian Cui, Yuzi Cai, Jin Lin, Xin Song, Zijun Zhou, Wantao Xiong, Huifang Zhou, Yuhong Bian & Li Wang. (2018) Tong-Xie-Yao-Fang Regulates 5-HT Level in Diarrhea Predominant Irritable Bowel Syndrome Through Gut Microbiota Modulation. Frontiers in Pharmacology 9.
Crossref
Crossref